A novel amino acid derivative 3-(4-(1, 2, 4, 5-tetrazine-3-yl) phenyl)-2-aminopropanoic acid was synthesized in this study. The compound possessed better water-solubility and was synthesized more easily compared with the well-known and commercially available 3-(p-benzylamino)-1, 2, 4, 5-tetrazine. Tetrazine-containing amino acid showed excellent stability in biological media and might be used for cancer cell labeling. Moreover, the compound remained relatively stable in 50% TFA/DCM with little decomposition after prolonged exposure at room temperature. The compound could be utilized as phenylalanine or tyrosine analogue in peptide modification, and the tetrazine-containing peptide demonstrated more significant biological activity than that of the parent peptide. The combination of tetrazine group and amino acid offered broad development prospects of the bioorthogonal labeling and peptide synthesis.
Tetrazine-Containing Amino Acid for Peptide Modification and Live Cell Labeling
Zhongqiu Ni,Lan-xia Zhou,Xu Li,Jing Zhang,S. Dong
Published 2015 in PLoS ONE
ABSTRACT
PUBLICATION RECORD
- Publication year
2015
- Venue
PLoS ONE
- Publication date
2015-11-04
- Fields of study
Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-37 of 37 references · Page 1 of 1
CITED BY
Showing 1-20 of 20 citing papers · Page 1 of 1